Medical devices; immunology and microbiology devices; classification of fecal calprotectin immunological test systems. Final rule.
The Food and Drug Administration (FDA) is classifying fecal calprotectin immunological test systems into class II (special controls). The special control that will apply to these devices is the guidance document entitled, "Class II Special Controls Guidance Document: Fecal Calprotectin Immunological Test Systems." The agency is classifying these devices into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of these devices. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of a guidance document that will serve as the special control for these devices.
D018795:Device Approval; D004869:Equipment Safety / Q000145:classification; D006801:Humans; D007118:Immunoassay / Q000145:classification* / Q000295:instrumentation; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis; D039841:Leukocyte L1 Antigen Complex / Q000145:classification / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
D039841:Leukocyte L1 Antigen Complex